T2 Biosystems (NASDAQ:TTOO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.64) by 10.94 percent. The company reported quarterly sales of $1.985 million which missed the analyst consensus estimate of $2.800 million by 29.11 percent. This is a 34.85 percent increase over sales of $1.472 million the same period last year.